Site US104 — Chicago, Illinois

Site US104 is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US104 has participated in 1 clinical trials.

Therapeutic areas: Castration-Resistant Prostate Cancer (CRPC).

Sponsors: Astellas Pharma Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US104?

Site US104 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US104 conducted?

Site US104 has 1 clinical trials on record. Their work covers Castration-Resistant Prostate Cancer (CRPC).

Is Site US104 accredited by Crixeo Health?

Site US104 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US104?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.